Loading clinical trials...
Loading clinical trials...
A [C-11]-PBR28 Positron Emission Tomography Study to Evaluate the Effect of ABT-555 on Central Nervous System Inflammation in Subjects With Relapsing Forms of Multiple Sclerosis
Conditions
Interventions
ABT-555
Locations
2
United Kingdom
Site Reference ID/Investigator# 141463
London, United Kingdom
Site Reference ID/Investigator# 141461
Whitechapel, United Kingdom
Start Date
October 1, 2015
Primary Completion Date
December 1, 2015
Completion Date
December 1, 2015
Last Updated
February 8, 2017
NCT07225504
NCT06276634
NCT06809192
NCT05359653
NCT07376772
NCT07426991
Lead Sponsor
AbbVie
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions